Healthcare

Is Edwards Lifesciences (NYSE:EW) Reinforcing Its Leadership in Medi...

Highlights,Edwards Lifesciences specializes in structural heart disease treatments and critical care monitoring solutions.,Institutional ownership cha...

Is BioCryst Pharmaceuticals (NASDAQ:BCRX) Advancing Its Position in...

Highlights,Russell Investments Group expanded its shareholding in BioCryst Pharmaceuticals during the latest quarter.,BioCryst Pharmaceuticals reporte...

What Are the Key Segments Driving Koninklijke Philips (NYSE:PHG) For...

Highlights,Koninklijke Philips delivers integrated health technology across diagnosis, connected care, and personal health segments.,Institutional own...

How Is Elanco Animal Health (NYSE:ELAN) Managing Innovation Amid Mar...

Highlights,Russell Investments Group Ltd. reduced its position in Elanco Animal Health by more than seventy percent.,Price target reassessments have b...

What Is Fueling Institutional Momentum Behind Medpace Holdings (NASD...

Highlights,Medpace’s quarterly performance surpassed revenue and earnings benchmarks.,Institutional investors, including Vanguard and Invesco, have no...

What Do Institutional Moves Reveal About Merit Medical Systems (NASD...

Highlights,Cerity Partners LLC reduced its position in Merit Medical Systems during the latest quarter.,Barclays PLC and JPMorgan Chase & Co. made sub...

How Are Structural Headwinds Shaping Avantor’s (NYSE:AVTR) Strategy?

Highlights,Avantor’s revenue declined in the recent quarter, missing market expectations.,The company’s five-year growth rate has remained below indus...

Envestnet Asset Management Inc. Increases Investment in Amicus Thera...

Highlights,Notable increase in institutional investments in the recent quarter,Analysts express mixed opinions on the stock's future performance,Overv...

Could Institutional Flows Reflect Changing Sentiment at Catalyst?

Could Institutional Flows Reflect Changing Sentiment at Catalyst?

Can Omnicell Maintain Institutional Momentum Amid Market Dynamics?

Can Omnicell Maintain Institutional Momentum Amid Market Dynamics?

Could Institutional Moves Fuel Twist’s Next Chapter?

Could Institutional Moves Fuel Twist’s Next Chapter?

Strategic Developments and Market Activity in AMN Healthcare Service...

Highlights:,Institutional Activity:,Several major financial entities expanded their positions in AMN Healthcare Services, indicating active engagement...

Leerink Partners Releases Negative Forecast for UNH Earnings

Highlights,UnitedHealth Group’s earnings estimates have been revised for the upcoming quarterly period.,The company retains a dominant presence in the...

Invesco Ltd. Reduces Its Holdings in ACADIA Pharmaceuticals Inc. (NA...

Highlights,Institutional Stake Adjustments,: Invesco Ltd. reduced its shareholding in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) during the most recent...

Is OrthoPediatrics (NASDAQ:KIDS) Becoming a Key Focus in Pediatric M...

Highlights,Geode Capital Management and Wellington Management Group expanded their holdings in OrthoPediatrics.,Triodos Investment Management signific...

Is Verona Pharma (NASDAQ:VRNA) Paving a New Path in Respiratory Care...

Highlights,Institutional investors, including Wells Fargo, significantly increased their holdings in Verona Pharma.,Key product candidate ensifentrine...

Is Blueprint Medicines (NASDAQ:BPMC) Becoming a Pivotal Name in Targ...

Highlights,Cerity Partners LLC initiated a new position in Blueprint Medicines during the fourth quarter.,Vanguard Group Inc. and Wellington Managemen...

What Role Does Innovation Play in Neogen’s (NASDAQ:NEOG) Market Resi...

Highlights,Major institutions, including Bank of Montreal and Vanguard Group Inc., adjusted their holdings in Neogen.,Norges Bank reported a significa...

Why Is iTeos Therapeutics Inc. (NASDAQ:ITOS) Gaining Ground in Bioph...

Highlights,Russell Investments Group Ltd. increased its holdings in iTeos Therapeutics during the fourth quarter.,Additional firms such as SG Americas...

What Makes Amicus Therapeutics (NASDAQ:FOLD) a Focal Point in Rare D...

Highlights,Russell Investments Group significantly expanded its position in Amicus Therapeutics during the fourth quarter.,Multiple financial entities...